Literature DB >> 30148765

Relationships of Microbiome Markers With Extraintestinal, Psychological Distress and Gastrointestinal Symptoms, and Quality of Life in Women With Irritable Bowel Syndrome.

Emily B Hollister1, Kevin C Cain2, Robert J Shulman3, Monica E Jarrett4, Robert L Burr4, Cynthia Ko5, Jasmine Zia5, Claire J Han4, Margaret M Heitkemper4.   

Abstract

INTRODUCTION: Altered microbial diversity has been associated with gastrointestinal (GI) symptoms in persons with irritable bowel syndrome (IBS). Less is known about the relationship of microbiome with extraintestinal pain and psychological distress symptoms and quality of life (QOL) in persons with IBS. We aimed to evaluate the relationship of fecal microbiota to GI symptoms, stool consistency, psychological distress, extraintestinal pain, and QOL in participants meeting Rome III criteria for IBS.
METHODS: Seventy-six women completed a 28-day diary that included GI, stool consistency, psychological distress, and extraintestinal pain ratings. Participants completed the IBS-Specific Quality of Life questionnaire. Stool samples were collected and analyzed by 16S rRNA gene sequencing. Principal component analysis was performed and the first 2 components (PC1, PC2) were used to test relationships among bacterial families and clinical measures.
RESULTS: Participants were categorized as IBS constipation (n=22), IBS diarrhea (n=39), IBS mixed (n=13), and IBS unsubtyped (n=2). There was a significant group effect for the Firmicutes to Bacteroidetes ratio and PC1. Lower microbial diversity and richness were associated with increased urgency and extraintestinal pain, worse QOL, and looser stools. Lower extraintestinal pain was associated with increased Rikenellaceae, Christensenellaceae, Dehalobabacteriaceae, Oscillospiraceae, Mogibacteriaceae, Ruminococcaceae, Sutterellaceae, Desulfovibrionaceae, and Erysipelotrichaceae abundances. QOL was positively associated with many of these same bacterial families. Higher Firmicutes to Bacteroidetes ratio was positively associated with loose stools. There were no statistically significant relationships between daily psychological distress or abdominal pain and bacterial families.
CONCLUSIONS: Stool microbial diversity and composition are linked to daily extraintestinal symptoms, stool consistency, and QOL in women with IBS.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 30148765      PMCID: PMC6387862          DOI: 10.1097/MCG.0000000000001107

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.174


  53 in total

1.  All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome.

Authors:  Debanjali Mitra; Keith L Davis; Robert W Baran
Journal:  Postgrad Med       Date:  2011-05       Impact factor: 3.840

2.  Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation.

Authors:  Gopanandan Parthasarathy; Jun Chen; Xianfeng Chen; Nicholas Chia; Helen M O'Connor; Patricia G Wolf; H Rex Gaskins; Adil E Bharucha
Journal:  Gastroenterology       Date:  2015-10-13       Impact factor: 22.682

3.  Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.

Authors:  Gangping Li; Min Yang; Yu Jin; Ying Li; Wei Qian; Hanhua Xiong; Jun Song; Xiaohua Hou
Journal:  J Gastroenterol Hepatol       Date:  2018-02-26       Impact factor: 4.029

4.  The Experience Sampling Method--a new digital tool for momentary symptom assessment in IBS: an exploratory study.

Authors:  Z Mujagic; C Leue; L Vork; R Lousberg; D M A E Jonkers; D Keszthelyi; M A Hesselink; T J C van Schagen; J van Os; A A M Masclee; J W Kruimel
Journal:  Neurogastroenterol Motil       Date:  2015-06-22       Impact factor: 3.598

5.  The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters.

Authors:  Kjersti Aagaard; Joseph Petrosino; Wendy Keitel; Mark Watson; James Katancik; Nathalia Garcia; Shital Patel; Mary Cutting; Tessa Madden; Holli Hamilton; Emily Harris; Dirk Gevers; Gina Simone; Pamela McInnes; James Versalovic
Journal:  FASEB J       Date:  2012-11-19       Impact factor: 5.191

6.  Breath Methane Excretion Is not An Accurate Marker of Colonic Methane Production in Irritable Bowel Syndrome.

Authors:  Michele Di Stefano; Caterina Mengoli; Manuela Bergonzi; Catherine Klersy; Elisabetta Pagani; Emanuela Miceli; Gino Roberto Corazza
Journal:  Am J Gastroenterol       Date:  2015-03-24       Impact factor: 10.864

7.  Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.

Authors:  Julien Tap; Muriel Derrien; Hans Törnblom; Rémi Brazeilles; Stéphanie Cools-Portier; Joël Doré; Stine Störsrud; Boris Le Nevé; Lena Öhman; Magnus Simrén
Journal:  Gastroenterology       Date:  2016-10-07       Impact factor: 22.682

8.  Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut.

Authors:  Henrik M Roager; Lea B S Hansen; Martin I Bahl; Henrik L Frandsen; Vera Carvalho; Rikke J Gøbel; Marlene D Dalgaard; Damian R Plichta; Morten H Sparholt; Henrik Vestergaard; Torben Hansen; Thomas Sicheritz-Pontén; H Bjørn Nielsen; Oluf Pedersen; Lotte Lauritzen; Mette Kristensen; Ramneek Gupta; Tine R Licht
Journal:  Nat Microbiol       Date:  2016-06-27       Impact factor: 17.745

9.  Insights into the Role of Erysipelotrichaceae in the Human Host.

Authors:  Nadeem O Kaakoush
Journal:  Front Cell Infect Microbiol       Date:  2015-11-20       Impact factor: 5.293

10.  NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth.

Authors:  Liang Chen; Justin E Wilson; Mark J Koenigsknecht; Wei-Chun Chou; Stephanie A Montgomery; Agnieszka D Truax; W June Brickey; Christopher D Packey; Nitsan Maharshak; Glenn K Matsushima; Scott E Plevy; Vincent B Young; R Balfour Sartor; Jenny P-Y Ting
Journal:  Nat Immunol       Date:  2017-03-13       Impact factor: 25.606

View more
  14 in total

1.  Human Adult Microbiota in a Static Colon Model: AhR Transcriptional Activity at the Crossroads of Host-Microbe Interaction.

Authors:  Elizabeth Goya-Jorge; Irma Gonza; Pauline Bondue; Caroline Douny; Bernard Taminiau; Georges Daube; Marie-Louise Scippo; Véronique Delcenserie
Journal:  Foods       Date:  2022-06-30

Review 2.  The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease.

Authors:  Orsolya Inczefi; Péter Bacsur; Tamás Resál; Csilla Keresztes; Tamás Molnár
Journal:  Front Nutr       Date:  2022-04-25

3.  Evaluation of the Effects of a Short Supplementation With Tannins on the Gut Microbiota of Healthy Subjects.

Authors:  Silvia Molino; Alberto Lerma-Aguilera; Nuria Jiménez-Hernández; José Ángel Rufián Henares; M Pilar Francino
Journal:  Front Microbiol       Date:  2022-04-27       Impact factor: 6.064

4.  Rifaximin Improves Visceral Hyperalgesia via TRPV1 by Modulating Intestinal Flora in the Water Avoidance Stressed Rat.

Authors:  Chang-Qing Yang; Xiao-Shu Guo; Zi-Bai Wei; Li Zhao; Gan-Ting Zhao; Shu-Ting Sheng
Journal:  Gastroenterol Res Pract       Date:  2020-07-20       Impact factor: 2.260

5.  Leveraging Microbiome Science From the Bedside to Bench and Back: A Nursing Perspective.

Authors:  Katherine A Maki; Paule V Joseph; Nancy J Ames; Gwenyth R Wallen
Journal:  Nurs Res       Date:  2021 Jan/Feb       Impact factor: 2.381

6.  Bile Acids and Microbiome Among Individuals With Irritable Bowel Syndrome and Healthy Volunteers.

Authors:  Kendra J Kamp; Kevin C Cain; Angelita Utleg; Robert L Burr; Daniel Raftery; Ruth Ann Luna; Robert J Shulman; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2020-07-15       Impact factor: 2.522

7.  Functional Gastrointestinal Disorders and the Microbiome-What Is the Best Strategy for Moving Microbiome-based Therapies for Functional Gastrointestinal Disorders into the Clinic?

Authors:  Ruben A T Mars; Mary Frith; Purna C Kashyap
Journal:  Gastroenterology       Date:  2020-11-28       Impact factor: 22.682

8.  A Comprehensive Self-Management Program With Diet Education Does Not Alter Microbiome Characteristics in Women With Irritable Bowel Syndrome.

Authors:  Kendra J Kamp; Anna M Plantinga; Kevin C Cain; Robert L Burr; Pamela Barney; Monica Jarrett; Ruth Ann Luna; Tor Savidge; Robert Shulman; Margaret M Heitkemper
Journal:  Biol Res Nurs       Date:  2021-01-08       Impact factor: 2.318

9.  Dysbiosis associated with acute helminth infections in herbivorous youngstock - observations and implications.

Authors:  Laura E Peachey; Cecilia Castro; Rebecca A Molena; Timothy P Jenkins; Julian L Griffin; Cinzia Cantacessi
Journal:  Sci Rep       Date:  2019-07-31       Impact factor: 4.379

10.  Altered Gut Microbiota Composition Is Associated With Back Pain in Overweight and Obese Individuals.

Authors:  Marloes Dekker Nitert; Aya Mousa; Helen L Barrett; Negar Naderpoor; Barbora de Courten
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-02       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.